Characterization of the normal adrenal gland with 18F-FDG PET/CT

Journal of Nuclear Medicine

Volumn 45, Issue 8, 2004, Pages 1340-1343

  Bagheri, Baharak ^a   Maurer, Alan H ^a,b,c   Cone, Libby ^a,b   Doss, Mohan ^b   Adler, Lee ^b  

^a TEMPLE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b FOX CHASE CANCER CENTER   (United States)

^c TEMPLE UNIVERSITY HOSPITAL   (United States)

Author keywords

18F FDG; Adrenal gland; PET CT; Standardized uptake value

Indexed keywords

FLUORODEOXYGLUCOSE F 18; DIAGNOSTIC AGENT; RADIOPHARMACEUTICAL AGENT;

ADRENAL FUNCTION; ADRENAL GLAND; ALGORITHM; ARTICLE; ATTENUATION; CLINICAL ARTICLE; COMPUTER ASSISTED TOMOGRAPHY; CONTROLLED STUDY; HODGKIN DISEASE; HUMAN; IMAGE ANALYSIS; LIVER FUNCTION; NONHODGKIN LYMPHOMA; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL; CLINICAL TRIAL; COMPARATIVE STUDY; COMPUTER ASSISTED DIAGNOSIS; COMPUTER ASSISTED EMISSION TOMOGRAPHY; CONTROLLED CLINICAL TRIAL; IMAGE SUBTRACTION; LYMPHOMA; METABOLISM; METHODOLOGY; OBSERVER VARIATION; RADIOGRAPHY; RANDOMIZED CONTROLLED TRIAL; REFERENCE VALUE; REPRODUCIBILITY; SCINTISCANNING; SENSITIVITY AND SPECIFICITY; STANDARD; VALIDATION STUDY;

ADRENAL GLANDS; FLUORODEOXYGLUCOSE F18; HUMANS; IMAGE INTERPRETATION, COMPUTER-ASSISTED; LYMPHOMA; OBSERVER VARIATION; RADIOPHARMACEUTICALS; REFERENCE STANDARDS; REFERENCE VALUES; REPRODUCIBILITY OF RESULTS; SENSITIVITY AND SPECIFICITY; SUBTRACTION TECHNIQUE; TOMOGRAPHY, EMISSION-COMPUTED; TOMOGRAPHY, X-RAY COMPUTED;

EID: 4544337742     PISSN: 01615505     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (16)

1. 18F-FDG PET in characterizing adrenal lesions detected on CT or MRI. J Nucl Med. 2001;42:1795-1799.
2. Boland G, Goldberg M, Lee M, et al. Indeterminate adrenal mass in patients with cancer: evaluation at PET with 2-(F-18)-fluoro-2-deoxy-D-glucose. Radiology. 1995;194:131-134.
3. 18F-fluorodeoxyglucose positron emission tomography. AJR. 1997;168:1361-1362.
4. Maurea S, Mainolfi C, Wang H, et al. Positron emission tomography (PET) with fludoeoxyglucose F 18 in the study of adrenal masses: comparison of benign and malignant lesions. Radiol Med (Torino). 1996;92:782-787.
5. Kenney P, Lee J. The adrenals. In: Heiken J, ed. Computed Body Tomography with MRI Correlation. 3rd ed. Philadelphia, PA: Lippincott-Raven; 1999:1171-1208.
6. Glazer H, Lee J, Balfe D, Mauro M, Griffeth R, Sagel S. Non-Hodgkin lymphoma: computed tomographic demonstration of unusual extranodal involvement. Radiology. 1983;149:211-217.
7. Jafri S, Francis I, Glazer G, Bree R, Amendola M. CT detection of adrenal lymphoma. J Comput Assist Tomogr. 1983;7:254-256.
8. Paling M, Williamson B. Adrenal involvement in non-Hodgkin lymphoma. AJR. 1983;141:303-305.
9. Reznek R, Husband J. Lymphoma. In: Husband JES, Razneck RH, eds. Imaging in Oncology. Vol 2. London, U.K.: Martin Dunitz; 1998:583-624.
10. Grado TR, Turkington TG, Williams JJ, Stearns CW, Hoffman JM, Coleman RE. Performance characteristics of a whole body PET scanner. J Nucl Med. 1994;35:1398-1406.
11. Maurea S, Klain M, Mainolfi C, Ziviello M, Salvatore M. The diagnostic role of radionuclide imaging in evaluation of patients with nonhypersecreting adrenal masses. J Nucl Med. 2001;42:884-892.
12. Shulkin BL, Thompson NW, Shapiro B, Francis IR, Sisson JC. Pheochromocytomas: imaging with 2-(fluorine-18)fluoro-2-deoxy-D-glucose PET. Radiology. 1999;212:35-41.
13. Netter F. Anatomy and blood supply of the suprarenal (adrenal) glands. The Ciba Collection of Medical Illustrations. Vol 4. New York, NY: Ciba Pharmaceutical Company; 1981:41-42.
14. Karstaedt N, Sagel S, Stanley R, Melson G, Levitt R. Computed tomography of the adrenal gland. Radiology. 1978;129:723-730.
15. Hamburg LM, Hunter GT, Albert NM, et al. The dose uptake ratio as an index of glucose metabolism: useful parameter or oversimplification? J Nucl Med. 1994;35:1308-1312.
16. Keyes JW. SUV: standard uptake or silly useless value? J Nucl Med. 1995;40:1784-1791.